Suven Pharmaceuticals Faces Mixed Performance Amid Broader Market Resilience

Suven Pharmaceuticals has experienced a notable decline of 4.32% on March 27, 2025, underperforming the broader sector by 4.4%. The stock opened the day with a loss of 2.01% and reached an intraday low of Rs 1100, marking a decrease of 4.93%.
In terms of moving averages, Suven Pharmaceuticals is currently positioned higher than its 200-day moving average but lower than its 5-day, 20-day, 50-day, and 100-day moving averages, indicating mixed short-term performance relative to longer-term trends.

In the broader market context, the Sensex has shown resilience, recovering from an initial drop of 201.11 points to trade at 77,433.72, reflecting a gain of 0.19%. The Sensex has been on a three-week upward trajectory, gaining 5.79% during this period.

Over various time frames, Suven Pharmaceuticals has shown contrasting performance. While it has gained 73.22% over the past year, its year-to-date performance stands at a decline of 2.25%. In the longer term, the stock has demonstrated significant growth, with a remarkable increase of 968.37% over the past five years, compared to the Sensex's 159.71% rise in the same period.